Certiva

Certiva (Certolizumab Pegol): Complete Guide to Uses, Dosage, Benefits, Side Effects & FAQS

Certiva is a potent prescription medication containing the active ingredient Certolizumab Pegol. It is categorized under Prescription Medicines, Autoimmune & Immunology Medicines, Rheumatology & Arthritis Medicines, Gastroenterology Medicines, and Biologics & Biosimilars. As a unique biological therapy, Certiva is designed to provide long-lasting relief for patients suffering from chronic inflammatory and autoimmune conditions.

---

Introduction to Certiva

Certiva is a specialized biologic medicine used to treat several serious inflammatory conditions, including Rheumatoid Arthritis, Crohn’s Disease, and Psoriatic Arthritis. Unlike traditional pills, Certiva is a monoclonal antibody that targets specific inflammatory proteins in the body. The active ingredient, Certolizumab Pegol, is unique because it is “pegylated,” meaning it stays in the body longer, allowing for less frequent dosing while providing consistent protection against tissue damage and inflammation.

Drug Class and Mechanism of Action

Certiva belongs to a class of drugs known as Tumor Necrosis Factor (TNF) blockers. The active ingredient, Certolizumab Pegol, works by binding to TNF-alpha, a protein in the immune system that causes inflammation. In people with autoimmune diseases, the body produces too much TNF-alpha, leading to pain, swelling, and organ damage. Certolizumab Pegol neutralizes this protein, effectively “switching off” the inflammatory response at its source. Because it lacks a specific portion of the antibody (the Fc region), it is also known for having minimal transfer across the placenta during pregnancy.

Medical Uses of Certiva

Certiva is approved for a variety of chronic conditions:

• Crohn’s Disease: Used to reduce signs and symptoms and maintain clinical response in adults with moderately to severely active disease.

• Rheumatoid Arthritis (RA): Prescribed to treat moderate to severe RA, helping to slow the progression of joint damage.

• Psoriatic Arthritis: Helps manage joint pain and skin symptoms associated with this condition.

• Ankylosing Spondylitis: Used for chronic inflammatory arthritis affecting the spine and large joints.

• Plaque Psoriasis: Effective for adults with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy.

Who Can Take Certiva?

Treatment with Certiva requires a comprehensive evaluation by a specialist (Rheumatologist or Gastroenterologist).

• Eligibility: Adults with confirmed autoimmune diagnoses who have not responded sufficiently to first-line treatments like methotrexate.

• Screening: Before starting Certolizumab Pegol, patients must be tested for Tuberculosis (TB) and Hepatitis B, as these infections can reactivate during treatment.

• Who Should Avoid It: Individuals with severe active infections or advanced heart failure should avoid this medication.

• Pregnancy Consideration: Due to its unique structure, Certolizumab Pegol is often a preferred biologic for women of childbearing age, as it has very low placental transfer.

Certiva Dosage and Administration

Certiva is not available as an oral tablet; it is administered via subcutaneous injection (under the skin).

• Initial Dosing (Loading): Treatment typically begins with a higher “loading dose” (usually at weeks 0, 2, and 4) to quickly bring inflammation under control.

• Maintenance Dose: After the initial phase, Certiva is usually injected once every 2 or 4 weeks, depending on the condition being treated.

• Self-Injection: Patients or caregivers can be trained to administer the injections at home using pre-filled syringes.

• Storage: The medication must be stored in the refrigerator and should reach room temperature before injection.

Benefits of Certiva

• Targeted Relief: Specifically blocks TNF-alpha, reducing the risk of systemic side effects seen with broad immunosuppressants.

• Joint Protection: Proven to slow down the physical progression of joint erosion in RA patients.

• Flexible Dosing: Maintenance schedules of every 2 or 4 weeks offer convenience for long-term management.

• Safety in Pregnancy: Clinical evidence suggests Certolizumab Pegol has the lowest placental transfer among TNF blockers, providing an option for pregnant patients.

Side Effects of Certiva

Common side effects of Certolizumab Pegol may include:

• Injection site reactions (redness, itching, or swelling).

• Upper respiratory tract infections (common cold or sinus infections).

• Urinary tract infections.

• Rash or headache.

Seek medical attention immediately if you notice:

• Signs of a severe infection (fever, chills, persistent cough).

• Shortness of breath or swelling of the ankles (heart issues).

• Numbness or tingling sensations (neurological issues).

• Unusual bruising or bleeding.

Warnings and Precautions

• Infection Risk: Certiva lowers the immune system’s ability to fight infections. Avoid contact with sick individuals.

• Malignancy Risk: As with all TNF blockers, there is a slightly increased risk of certain types of cancer, such as lymphoma or skin cancer.

• Vaccinations: Live vaccines should not be given while using Certolizumab Pegol.

• Regular Monitoring: Periodic blood tests are necessary to monitor liver enzymes and blood cell counts.

Certiva Price, Availability & Generic Options

The price of Certiva can vary significantly based on the country, insurance coverage, and specialty pharmacy. As a complex biologic medication, it is typically more expensive than traditional drugs. While Certolizumab Pegol is primarily available under major brand names, biosimilar versions are in development or available in certain regions, providing more affordable options for patients while maintaining the same efficacy.

Frequently Asked Questions (FAQs)

1. How long does it take for Certiva to start working? Some patients feel improvement within 2 to 4 weeks, though the full effect of Certolizumab Pegol may take up to 12 weeks.

2. Can I travel with Certiva? Yes, but since Certiva must be refrigerated, you must use a specialized cool bag to maintain the cold chain during travel.

3. Is Certiva a steroid? No. It is a biologic TNF-blocker, which is a different class of medicine than corticosteroids.

4. Do I need to take it forever? Autoimmune conditions are chronic. Most patients stay on Certolizumab Pegol long-term to prevent symptoms from returning.

Conclusion

Certiva (Certolizumab Pegol) is an advanced biological therapy that offers a lifeline to patients with debilitating inflammatory diseases. By precisely neutralizing the proteins that drive inflammation, it helps restore mobility, clear skin, and improve digestive health. When used under professional guidance, Certiva serves as a vital tool for achieving long-term disease remission.

Medical Disclaimer: This content is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication.